Lantern Pharma Announces Three U.S. FDA Rare Pediatric Disease Designations Granted to LP-184 in Multiple Ultra Rare Children’s Cancers
lantern pharma宣佈,LP-184在多種超稀有兒童癌症中獲得了三項美國FDA罕見兒科疾病認定。
Lantern Pharma Announces Three U.S. FDA Rare Pediatric Disease Designations Granted to LP-184 in Multiple Ultra Rare Children’s Cancers
lantern pharma宣佈,LP-184在多種超稀有兒童癌症中獲得了三項美國FDA罕見兒科疾病認定。
譯文內容由第三人軟體翻譯。